Trial Profile
PROSPECTIVE ANALYSIS BETWEEN TRIMETAZIDINE Versus PLACEBO IN MYOCARDIAL INJURY AFTER PERCUTANEOUS CORONARY INTERVENTION IN PATIENTS WITH INSTANT ANGINA AND DIABETES MELLITUS
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 08 Oct 2021
Price :
$35
*
At a glance
- Drugs Trimetazidine (Primary)
- Indications Myocardial infarction
- Focus Therapeutic Use
- Acronyms Trimeta
- 29 Oct 2018 New trial record